The drug Carfilzomib is sold under the trade name Kyprolis. It is used in treating patients with multiple myeloma and has received at least a couple of prior therapies, including bortezomib and an immunomodulatory agent. Carfilzomib is a tetrapeptide epoxyketone proteasome inhibitor that irreversibly binds to the N-terminal threonine-containing active sites of the 20S proteasome, the proteolytic core particle within the 26S proteasome. It is an antineoplastic agent available for intravenous use only, and it comes in 60 mg single-use vials. The active ingredient in the vials is Carfilzomib, with inactive ingredients sulfobutylether beta-cyclodextrin, citric acid, and sodium hydroxide. There is no known specific antidote for Carfilzomib overdosage. In an overdose, monitor the patient and provide appropriate supportive care.
Carfilzomib injection price is budget-friendly, and anyone can purchase this medication from licensed pharmaceutical suppliers in India. If anyone wants to know more about this drug, ring us on 18008891064.